Introduction
The endocytic pathway is essential for the delivery of membrane components, receptor-bound ligands and soluble molecules to different intracellular organelles. It requires the concentration of cargo molecules, the formation and detachment of transport vesicles from donor compartments and the subsequent fusion with proper target compartments. The formation of vesicles is driven by the assembly of specific coat proteins that work in conjunction with additional accessory and regulatory machinery. The most well characterized internalization process is the formation of clathrin-coated vesicles. The proper formation and Proteins that specifically regulate transport from the ERC include the small GTPase Rab11 (Chen et al., 1998; Ren et al., 1998) and EHD1 . In mammals, EHD1 belongs to a family of four highly related proteins (EHD1-4) (Mintz et al., 1999; Pohl et al., 2000) that share a very similar domain structure with an N-terminal P-loop-containing nucleotide binding domain, a central region predicted to form coiled coils and a C-terminal Eps15 homology (EH) domain. The C. elegans homologue RME-1 was identified in a genetic screen for mutants defective in the receptor-mediated endocytosis of yolk protein. Closer examination of rme-1 mutants indicated that a block in endocytic recycling was the primary defect . The expression of a mRme-1/EHD1 G429R mutant, designed by analogy to a dominant C. elegans mutant (G459R), resulted in the redistribution of the ERC in mammalian cells and slowed the recycling of transferrin receptors , of major histocompatibility complex class I molecules (MHC-I) (Caplan et al., 2002) , the cystic fibrosis transmembrane conductance regulator (Picciano et al., 2003) and AMPA-type glutamate receptors (Park et al., 2004) back to the cell surface. Depletion of mRme-1/EHD1
by RNA interference confirmed the role of mRme-1/EHD1 in mammalian cell protein recycling to the cell surface (Naslavsky et al., 2004) . Here we identify EHD proteins as differential interaction partners of syndapins. We examine the molecular requirements for these interactions as well as means of regulation. Furthermore we demonstrate that the ability of mRme-1/EHD1 to form protein complexes through EH domain/NPF interactions is crucial for the recycling process.
Materials and Methods

DNA Constructs and Recombinant Proteins
Constructs coding for glutathione S-transferase (GST)-fusion proteins of syndapin I, syndapin I ΔSH3 and the short and long splice variants of syndapin II and for a Maltose-binding protein (MBP)-fusion protein of syndapin I ΔSH3 were described previously (Qualmann et al., 1999; . Further GST-fusion proteins, such as syndapin I SH3 domain (aa 378-441), syndapin II SH3 domain (aa 422-488) and the NPF motif regions of syndapin I (aa 336-386), syndapin II-s (aa 338-387) and syndapin were generated by PCR on appropriate templates and cloning into pGEX vectors. Mammalian expression constructs encoding green fluorescent protein (GFP) or Flag-tagged syndapins and fragments thereof were generated by subcloning into pEGFP-C1 (Clontech) and pCMV-Tag2B (Stratagene), respectively. Xpress-tagged syndapin II-l and syndapin II-l ∆SH3 were described in . For yeast two-hybrid analyses, syndapin I full length and syndapin I ΔSH3 were inserted into the pGBTK7 vector. The plasmid encoding mitochondriatargeted full-length syndapin I was described in Kessels and Qualmann (2002) . Point mutations in the NPF motifs of syndapin I and II-l resulting in the exchange of phenylalanine to valine were introduced by site directed mutagenesis via PCR. Syndapin III was amplified by PCR from a rat retina library (Seidenbecher et al., 2004) and cloned into EcoRI-SalI sites of pGEX-5X1 (Amersham).
GST-mRme-1/EHD1 full-length and GST-EH domain (aa408-534) expression constructs were created by PCR with full-length mRme-1/EHD1 as template and cloned into pGEX-2T.
Full-length Flag-mRme-1/EHD1, EGFP-mRme-1/EHD1 wild-type, G65R, and G429R constructs were described previously . The W485A mutation was engineered into the full length EGFP-mRme-1/EHD1 construct using appropriate mutation primers GST-and MBP-fusion proteins were expressed and purified, as described previously (Qualmann et al., 1999; Kessels et al., 2000) .
Antibodies
Rabbit anti-syndapin I and anti-syndapin II antibodies, guinea pig anti-syndapin II antibodies (antisera 2521, 2704 and P339) and anti-GST antibodies were described previously (Qualmann et al., 1999; .
Polyclonal anti-syndapin I antibodies were raised in guinea pig (Pineda Antikörper-Service, Germany) against a purified GST-fusion protein of amino acid residues 1-382 of rat syndapin I. Antibodies were affinity purified on GST and MBP-syndapin I (aa 1-382) blotted to nitrocellulose membranes.
Polyclonal anti-mRme/EHD antibodies were raised in rabbit (Covance Immunological Services, USA) against a synthetic peptide (CADLPPHLVPPSKRRHE), corresponding to the extreme C-terminus of the mouse Rme-1/EHD1 protein, conjugated to keyhole lympet hemocyanin. Antisera raised against this peptide were affinity purified against immobilized antigenic peptide (Sulfolink Kit) according to the manufacturer's instructions (Pierce, USA).
Due to high sequence conservation the antibodies also recognize the EHD protein isoforms 3 and 4 relatively well ( Figure S1 ) and work for several species, such as mouse, rat and human.
Monoclonal anti-Flag (M2) and anti-synaptophysin antibodies were from Sigma, monoclonal anti-GFP (B34) antibodies were from Babco, monoclonal anti-TGN38 antibodies were from Transduction Laboratories and monoclonal anti-Xpress antibodies were from Invitrogen.
Secondary antibodies used include goat anti-mouse-peroxidase and goat anti-rabbitperoxidase from Dianova, goat anti-guinea pig-peroxidase and FITC goat anti-guinea pig from BD Biomedicals as well as Alexa Fluor TM 488 goat anti-mouse, Alexa Fluor TM 568 goat anti-mouse, Alexa Fluor TM 568 goat anti-rabbit, Alexa Fluor TM 647 goat anti-mouse and
Tissue Fractionation
Tissue fractionation was carried out essentially as described in Qualmann et al. (2004) . In brief, rat brain cortices and hippocampi were homogenized in 320 mM sucrose, 5 mM HEPES, pH 7.4. The homogenate was centrifuged at 1000 x g to remove cell debris and nuclei and the resulting low-speed supernatant (S1) was recentrifuged at 12,000 x g for 15 min. While the obtained supernatant S2 was further fractionated by centrifugation at 100,000
x g for 1 h yielding a microsomal pellet (PM) and a ultra-high speed supernatant (SM), the resulting pellet P2 (crude membrane fraction) was loaded onto a sucrose step gradient (0.85/1.0/1.2 M). Myelin, light membranes, and synaptosomes were isolated at the different sucrose interfaces. The mitochondria-and heavy-membrane-containing fraction (mitochondria) was obtained as pellet. Synaptosomal membranes were isolated after the osmotic lysis of synaptosomes in 1 mM TRIS/HCl, pH 8.1 for 30 min by centrifugation at 33,000 x g for 30 minutes. The samples were analyzed by SDS-PAGE and immunoblotting.
Coimmunoprecipitation from Rat Brain Extract
Rat brain extracts were prepared as described and precleared by incubation with protein A agarose (Santa Cruz) in 5% BSA in PBS. Equal amounts of affinity-purified guinea pig anti-syndapin I antibodies or unrelated guinea pig immunglobulins G (IgG) were immobilized onto protein A agarose in 5% BSA in PBS. After several washes with immunoprecipitation (IP) buffer (10 mM HEPES, 1 mM EGTA, 0.1 mM MgCl 2 , 50 mM NaCl, 1% Triton-X-100, pH 7.4), 1 mg protein of rat brain extract was added.
Beads were incubated for 3 h at 4°C, washed with IP buffer and eluted with SDS sample buffer. Eluates and supernatants were separated on SDS-PAGE and analyzed by immunoblotting.
Preparation of Cell Extracts and Coimmunoprecipitation
For immunoprecipitations of epitope-tagged proteins, HEK293 cells were transiently cotransfected with different GFP-and Flag-tagged constructs, grown for additional 40 hours, harvested and lysed in IP-buffer containing 100 mM NaCl. Insoluble material was removed by centrifugation.
Anti-Flag antibodies or unrelated mouse IgG (Santa Cruz) were coupled to Protein G Sepharose beads (Amersham) at 4ºC for 5 h. In some experiments, antibodies were subsequently covalently linked to beads by Dimethyl-pimelimidate-dihydrochloride (Fluka) for 45 minutes at room temperature (Schneider et al., 1982) and HEK293 cell lysates were preincubated at room temperature for 10 minutes with AMP, ADPβS, ATPγS or ATP (all from Sigma) and MgCl 2 (final concentration each 5 mM). Lysates were incubated with the antibody-coated beads overnight at 4ºC. The beads were washed with IP-buffer and eluted immunoprecipitates were subjected to immunoblot analysis.
Yeast two-Hybrid Analyses
Y2H-screenings were performed using the GAL4-based MATCHMAKER yeast two-hybrid system 3 (Clontech) with full-length syndapin I as a bait. Both a rat brain cDNA library and a pretransformed mouse brain library (Clontech) were screened. Prey plasmids were isolated, retransformed into yeast and mated with yeast strains transformed with BD-syndapin I, BDsyndapin I ∆SH3 and with the pGBTK7 vector encoding for the BD domain alone. The diploids were subsequently assayed for the activation of reporter genes, as described in Kessels and Qualmann (2002) .
Cell Culture and Immunofluorescence Microscopy
HEK293, HeLa and COS-7 cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. Primary hippocampal cultures were prepared and grown as described Qualmann et al., 2004) .
Primary neurons 15 DIV were transfected using Lipofectamin 2000 (Invitrogen). 24 h after transfection, the cells were processed for immunofluorescence, as described . For the evaluation of the specificity and affinity of the guinea pig anti-syndapin I antibodies, COS-7 cells were transiently transfected using the FuGENE TM reagent (Roche).
For mitochondrial targeting experiments, HeLa cells were transfected with Polyfect reagent (Qiagen).
Cells were fixed and processed for immunofluorescence according to .
For mitochondrial staining, cells were incubated with MitoTracker ® Red CMXRos (Molecular Probes), as described . Images were recorded digitally using a Leica TCS SP2 AOBS ® confocal microscope or a Leica DMRD fluorescence microscope and a Zeiss Axioplan 2 microscope both equipped with a CCD camera 2.1.1 from Diagnostic Instruments and processed in MetaVue and Adobe Photoshop.
Transferrin Internalization Assay
COS-7 cells were subjected to transferrin uptake assays 48 h after transfection, as described previously Kessels and Qualmann, 2002) . COS-7 cells treated with BioPorter ® according to the manufacturer's instructions (Gene Therapy Systems Inc.) to introduce immunoreagents were subjected to endocytosis assays 5 h after start of treatment. In order to be able to see putative dose-responses, cells were split in three categories differing in the extent of uptake of immunoreagent by the BioPorter ® method, as described by Kessels and Qualmann (2002 
Results
Identification of EHD proteins as binding partners for syndapin I
Syndapin proteins are involved in vesicle formation processes and in modulation of the actin cytoskeleton, as they interact with the GTPase dynamin and with the Arp2/3 complex activator N-WASP through their C-terminal SH3 domain .
Since syndapins contain several additional protein-protein interaction modules such as predicted N-terminal coiled coil domains, NPF motifs and a variety of consensus sites for different kinases, syndapins may act as multidomain scaffolding proteins integrating several different cellular functions. The three syndapin isoforms expressed in mammals show a highly conserved domain structure ( Figure 1A ). At the amino acid level, conservation between the isoforms is also very high. This is especially true for the C-terminal SH3 domains ). An exception are the NPF motif-containing regions Nterminal of the SH3 domains. They differ both in amino acid composition and in number of the NPF motifs. NPF motifs are absent in syndapin III ( Figure 1A ).
In yeast two hybrid screens with a syndapin I full-length bait ( Figure 1A Figure 1D ). The interaction was independent of the syndapin SH3 domain ( Figure 1C and D). We verified the interaction by affinity purification experiments.
Both a C-terminal fragment and full-length EHD3 fused to GST specifically precipitated endogenous syndapin I from rat brain cytosol ( Figure 1E ).
EH domains are present in a variety of proteins involved in membrane trafficking processes.
Thus, we asked if the syndapin interaction is restricted to EHD3, or whether it also occurs with multiple members of the EHD protein family or whether the interaction is promiscuous for many EH domain-containing proteins ( Figure 1F ). Syndapin I was successfully coprecipitated from rat brain extracts by immobilized GST-fusion proteins of full-length mouse Rme-1/EHD1 and of the only member of the EHD protein family in C. elegans, ceRme-1 ( Figure 1F ). The EH domain of mouse Rme-1/EHD1 alone was sufficient for the interaction. Interestingly, the EH domains of both Eps15 and intersectin failed to interact with syndapin I although all three EH domains of Eps15 and the two EH domains of intersectin were used ( Figure 1F ). Syndapin I thus exhibits specificity for EH domains found in members of the EHD protein family.
EHD proteins are differential binding partners of the syndapin family
We next evaluated whether the identified interaction with EHD proteins is a specialty of The observed differential associations of syndapins ( Figure 2B ) prompted us to examine putative specificities for different EHD proteins as well. We therefore cloned all four mouse EHD isoforms, which are highly conserved and despite the phylogenetic distance also show a high homology with the C. elegans ortholog ( Figure 2H ). Immobilized GST-fusion proteins of syndapin I ( Figure 2J ), syndapin II-s ( Figure 2K ) and syndapin II-l ( Figure 2L ), but not GST alone (data not shown) efficiently precipitated GFP-mRme-1/EHD1, GFP-EHD3 and GFP-EHD4 from HEK293 cell extracts. The amount of GFP-EHD2 within the precipitates of all three syndapins was low (Figures 2J-L). Thus, syndapins strongly bound only to three of the four EHD proteins, the relatively widely distributed mRme-1/EHD1, which our phylogenetic analyses suggest to be closest to the EHD ancestor (data not shown), EHD3, an isoform highly expressed in brain but also occurring in other tissues and the heart-enriched EHD4 (Pohl et al., 2000; Galperin et al., 2002) . EHD1, 3 and 4 show a good expression overlap with the syndapin isoforms I and II and their splice variants. In contrast, the isoform not effectively bound by syndapins, EHD2, is highly expressed in muscle tissues (Pohl et al., 2000) where expression of syndapin I and II is very low and not detectable, respectively .
Syndapin NPF motifs are crucial for the association with the EH domain of EHD proteins and the interaction is direct
Our in vitro analyses clearly demonstrated that regions of syndapins that contain NPF motifs are sufficient for the interaction with EHD proteins (Figure 2 ). In order to directly prove that the NPF motifs are crucial and to identify which of the several NPF motifs is responsible for the interaction, we mutated all NPF motifs in syndapin I and II individually and in The presence of at least two syndapin NPF motifs is also important for EH domain binding in the full-length context of EHD. Wild-type syndapin II-l was almost quantitatively precipitated from the cell extracts by full-length mRme-1/EHD1 but binding was almost completely abolished in mutants with a single NPF to NPV amino acid exchange. Only for syndapin II-l F421V some binding to full-length mRme-1/EHD1 was observed ( Figures 3E and F) . Thus, the interaction is highly dependent on the presence of multiple NPF motifs within syndapins.
Our analyses of the binding interfaces showed that both NPF motifs and EH domains are required and sufficient for the interaction. As these motifs are known to interact, this suggested that the interaction between syndapins and EHD proteins may be direct. To prove this, we overlayed lysates from HEK293 cells containing GFP-syndapin II-l or GFP as a control ( Figure 3G ) with a GST-EH domain probe. In the lane with the overexpressed GFPsyndapin II-l, the GST-EH probe readily detected a 90 kD band that was absent in the GFP control lane ( Figure 3I ) and corresponded well with the band of GFP-syndapin II-l obtained by anti-GFP immunoblotting ( Figure 3G ). Additionally, several weaker bands were revealed by the GST-EH domain at about 60 kD, 120 kD and 170 kD in the lane with GFP-syndapin II-l. As these were absent from the HEK293 cell lysate containing GFP alone and were not detected by anti-GFP antibodies, they cannot represent endogenous proteins or GFP fusion proteins, but instead are likely to represent syndapin II-l proteins released from GFP by proteolysis. The molecular weights that we observed fit with syndapin II-l monomers (60 kD), syndapin II-l dimers (120 kD) and syndapin II-l trimers (about 170 kD). In contrast, GST alone used as a control probe did not yield any signal ( Figure 3H ). These blot overlay studies formally demonstrate a specific and direct interaction of syndapins with the EH domain of EHD proteins.
Syndapins and EHD proteins are codistributed in neuronal and non-neuronal cells
To address in which cells and subcellular compartments the interaction between syndapins and EHD proteins might be of physiological importance, we subsequently performed colocalization studies (Figure 4 ). For this purpose, we raised new anti-syndapin I antibodies in guinea pigs. In immunoblot analyses, they recognized a single band of the expected size for syndapin I (about 50 kD) in brain extracts ( Figure 4A , lanes 1 and 2) and also detected recombinant MBP-syndapin I ∆SH3 (lane 3) with high affinity. In immunofluorescence examinations, they detected Flag-tagged mito-syndapin I expressed in COS-7 cells ( Figure   4D ) as specifically and efficiently as anti-Flag antibodies applied in parallel ( Figure 4B ). In primary hippocampal neurons kept in culture for two days, syndapin I was localized to the soma and to neurites and displayed accumulations at actin-rich growth cones ( Figure 4G ; arrow). The distribution of anti-EHD immunosignal was very similar ( Figure 4E ) and overlapped well with that of syndapin I ( Figure 4F ).
As described previously (Qualmann et al., 1999) , in mature neurons, syndapin I adopts a more punctate synaptic distribution in addition to the neuritic localization, as seen best in low density cultures at lower magnification ( Figure 4J ). Anti-EHD immunosignals (Figure 4H) were also obtained throughout neurites and showed in part strong accumulations at puncta that were always also immunopositive for syndapin ( Figure 4J ; arrowheads). These were often at sites where neurites contacted one another ( Figures 4H-J) . At higher magnification, we observed a very exact spatial overlap of anti-syndapin I and anti-EHD immunosignals at sites that are likely to represent synapses ( Figure 4K -M).
Analyses of endogenous syndapin II in cultured neurons were precluded by low syndapin II expression in brain . We thus slightly overexpressed syndapin II-l ( Figure 4P ) together with GFP-mRme-1/EHD1 ( Figure 4N ) in primary hippocampal neurons.
The merge of both images demonstrates the observed very high spatial overlap of both proteins in dot-like structures of a single transfected cell that often protrude from the neurites and may represent synaptic sites ( Figure 4O ). Both proteins also colocalized in cell somata (data not shown). Since both proteins were coexpressed in single, isolated cells within the neuronal cultures and showed a colocalization within these cells it can be firmly concluded that the two proteins coexist in puncta representing the same synaptic compartment, i.e. it can be excluded that the two proteins are separated by the synaptic cleft between a pre-and a postsynaptic neuron. As these puncta were observed in several neurites originating from the cell, we can furthermore conclude that syndapin and EHD1 coexist in the dendritic compartment and that the puncta thus represent postsynapses. A putative presynaptic localization of EHD1 remains to be confirmed by immunoelectron microscopy.
In non-neuronal cells, such as HeLa cells, Flag-mRme-1/EHD1 ( Figure 4Q ) and GFPsyndapin II-l ( Figure 4S ) also showed a strong spatial overlap, especially at structures that appeared tubular and vesicular ( Figure 4R ). Our immunofluorescence data suggest that syndapins and EHD proteins both localize to several cellular membrane compartments. Biochemical subcellular fractionation analyses and preparations of different membrane and synaptic compartments from brain homogenates indeed revealed that EHD proteins are especially abundant in membrane-associated fractions but low in fractions that contain more soluble proteins ( Figure 5A ). Strong anti-EHD immunosignals were seen in the crude membrane fraction P2, while in the corresponding supernatant S2, the signal was very low. The fractionation of S2 showed that this material mostly reflected microsomal pellet material. When the crude membrane fraction P2 was analyzed further, it became obvious that EHD immunoreactivity was enriched strongest in the light membrane-enriched fraction and was especially low in the fraction containing mitochondria and heavy membranes. Our preparations of synaptosomes and synaptic membranes were positive for anti-EHD immunosignals ( Figure 5A ).
Syndapin I showed a distribution quite similar to that of EHD proteins ( Figure 5B ). Both the material obtained in S2 and in the crude membrane fraction P2 fractionated further in a manner identical to that of EHD proteins. As the EHD immunoreactivity, syndapin I accumulated in the microsomal pellet rather than in the high speed cytosol. Also similar to the anti-EHD pattern, syndapin I was readily detected in light membranes and synaptosomes but absent from the heavy membranes-and mitochondria-containing fraction ( Figure 5B ; mitochondria). Together with EHD, syndapin I was detectable in the preparation of synaptic membranes ( Figure 5B ). The anti-syndapin II immunosignal was extremely weak (data not shown). The low immunosignals obtained are in line with the fact that the expression level of the more ubiquitously expressed syndapin II isoform is low in brain .
The similarity of the subcellular fractionation pattern of EHD proteins and syndapin I is highlighted best by comparison with other proteins, such as the synaptic vesicle protein synaptophysin ( Figure 5C ) and the trans-Golgi marker TGN38 ( Figure 5D ). Synaptophysin, in contrast to syndapin and EHD, can not be detected in the SM fraction but for example strongly accumulates in synaptosomes and in the preparation of synaptic membranes ( Figure   5C ). TGN38 shows a very different pattern. Very little TGN38 was found in the synaptosome fraction. Also, TGN38 is abundant in S2 and relatively scarce in P2. No TGN38 immunoreactivity was at all detected in the synaptic membrane preparation ( Figure 5D ).
Syndapin I and syndapin II-l interact with EHD proteins in vivo
To address whether syndapins and EHD proteins interact in vivo we coexpressed GFPsyndapin II-l (Figures 6 A-D) or GFP-syndapin I ( Figure S2 ) together with Flag-tagged mRme-1/EHD1 in HEK293 cells and subjected the lysates to coimmunoprecipitations. In both experimental series, Flag-mRme-1/EHD1 was effectively and specifically immunoprecipitated by anti-Flag antibodies ( Figures 6B and S2) , while in the control experiments Flag-mRme-1/EHD1 remained in the supernatants (Figures 6A and S2) . GFPsyndapin II-l was specifically coimmunoprecipitated with Flag-mRme-1/EHD1 by anti-Flag antibodies but not by the control IgGs ( Figure 6D ). GFP was not coimmunoprecipitated demonstrating that indeed the syndapin part interacts with mRme-1/EHD1 (data not shown;
compare Figure 10 ). Consistent with our in vitro data, GFP-syndapin I was also specifically coimmunoprecipitated with Flag-mRme-1/EHD1 ( Figure S2 ).
We were also able to specifically immunoprecipitate endogenous syndapin I from rat brain extracts with our guinea pig anti-syndapin I antibodies ( Figure 6E ). EHD protein was specifically coimmunoprecipitated ( Figure 6F ) showing that syndapin/EHD protein complexes exist in vivo.
The strength of the EH domain-mediated interaction of mRme-1/EHD1 with syndapin II is sufficient for a recruitment of syndapin to intracellular membranes in vivo
As EHD proteins were found to be predominantly membrane-associated ( Figure 5 ), a property that is consistent with its subcellular localization ( Figure 4 ) and proposed function Caplan et al., 2002; Naslavsky et al., 2004) , we next assayed whether EHD proteins would be able to recruit cytosolic syndapins to intracellular membranes. We constructed a mitochondrially targeted EH domain of mRme-1/EHD1 fused to GFP. This fusion protein was effectively targeted to the outer mitochondrial membrane of HeLa cells ( Figure 7A ), as
shown by MitoTracker® staining ( Figure 7C ). When full-length syndapin II-l was coexpressed, it adopted a mitochondrial localization pattern ( Figure 7F ) overlapping exactly with mito-GFP-EH-coated mitochondrial membranes ( Figure 7D ). Also syndapin II-l ∆SH3 
Acute interference with syndapin protein complexes by introduction of anti-syndapin antibodies inhibits endocytosis
The recycling function of mRme-1/EHD1 was first revealed by dominant negative studies ) that were later corroborated by a generalized reduction in mRme1/EHD1
protein levels via RNAi (Naslavsky et al., 2004 ). Since we found that syndapins and EHD proteins associate tightly in vivo, we sought to determine whether syndapins function with EHD proteins in receptor recycling. One method we applied to this problem was a general 
Transferrin receptor recycling is impaired by overexpression of syndapin II-l NPF motifs, the binding interface for EHD proteins
The above experiments show that interfering with syndapin functions in total introduces a block early in the endocytic pathway, at the step of vesicle formation at the plasma membrane and thus precluded to address syndapin functions in processes further down-stream of endocytic vesicle formation. We hypothesized that mechanistic details of a potential recycling function for syndapin might be revealed by specifically disrupting interactions of certain domains of syndapins rather than by interfering with the protein in toto. A prerequisite is that -unlike the SH3 domain Kessels and Qualmann, 2002 ) -these domains must not be involved in vesicle formation at the plasma membrane. Therefore, we turned to dominant-negative experiments to interfere specifically with the assembly of syndapin/EHD complexes. If such a particular syndapin interaction is required for recycling but not for internalization, then overexpression of the domains from either syndapins or an EHD protein mediating that interaction would be expected to inhibit recycling and trapp endocytic cargo in the endosomal recycling compartment.
In order to be able to test this hypothesis, we first characterized all such reagents for putative defects prior to recycling. As already reported for full-length syndapin II-l , overexpression of the NPF region of syndapin II-l and its corresponding NPF to NPV triple mutant did not cause any significant uptake defects ( Figure S3 ).
Furthermore, no significant endocytic internalization defects were observed upon overexpression of various mRme-1/EHD1 constructs. Only the G429R mutant showed a modest impairment of transferrin uptake, as only about 70% of the cells showed wild-type internalization ( Figure S3 ).
Thus we next assayed receptor recycling using methods similar to those described by . alone. This highlights the high potential of full-length mRme-1/EHD1 to rescue the phenotype caused by overexpression of syndapin NPFs and suggests that such EH-domain mediated mRme-1/EHD1 interactions are crucial for receptor trafficking back to the plasma membrane.
Receptor recycling is impaired by EH domain overexpression and can be rescued by syndapin cooverexpression
As the specific interference with EH domain functions by overexpression of its syndapin interaction interface led to impairments in receptor recycling ( Figures 9A-D) , we next asked whether interfering with NPF/EH domain interactions from the opposite side of the association interface would also inhibit. Indeed, overexpression of a GFP-tagged EH domain inhibited recycling, as shown by the significantly increased transferrin retention in transfected cells ( Figure 9E ). Quantitation of the dominant-negative effects revealed that the impairment was almost as strong as the effect caused by the syndapin NPF motifs and highly significant.
41% of all GFP-EH domain overexpressing cells showed a readily observable endosomal
transferrin fluorescence compared to only 22% in GFP controls ( Figure 9H ).
We subsequently tried to rescue the GFP-EH domain effect by cooverexpression of fulllength, i. e. presumably functional, syndapin. We first assayed whether overexpression of syndapin alone would have any negative effects on recycling of transferrin. Both Xpress-and
Flag-tagged syndapin II-l overexpressing cells showed a transferrin recycling indistinguishable from that of untransfected or GFP-expressing cells (Figures 9F and H).
Upon double transfection of Flag-syndapin II-l and mRme-1/EHD1 EH domain (Figures 9G),
we observed a normal recycling indicating a rescue of the EH domain induced phenotype.
Only 28% of all double transfected cells remained positive for fluorescent transferrin compared to 41% in the experiments with the EH domain alone ( Figure 9H) . Thus, about 66% of the effect caused by overexpression of the EH domain was rescued by coexpression of the mRme-1/EHD1 binding partner syndapin II-l. The values obtained upon our rescue experiments did not significantly differ from control, as revealed by statistical analyses. These data indicate that complexes of syndapins and EHD proteins play an important role in receptor recycling.
EH domain interactions with syndapins seem to be controlled by the nucleotide-binding domain of mRme-1/EHD1 in vitro and in vivo
Our data show that interfering with NPF/EH domain interactions is sufficient to impair recycling -a phenotype previously attributed to EHD in total (Naslavsky et al., 2004) . One of the endocytosis-deficient C. elegans RME-1 mutants carried a mutation in the nucleotide Ploop located within the N-terminus of all EHD proteins Figures 10A and B) . Flag-mRme-1/EHD1 was immunoprecipitated equally well under all of these conditions ( Figure 10B ). GFP-syndapin II-l specifically coimmunoprecipitated with Flag-mRme-1/EHD1 ( Figure   10A ). The coimmunoprecipitation was dependent on the syndapin part of the GFP-fusion protein because coexpressed GFP did not coimmunoprecipitate ( Figure 10C ) with FlagmRme1/EHD1 immunoprecipitated by anti-Flag antibodies ( Figure 10D ). The amounts of GFP-syndapin II-l coimmunoprecipitated differed clearly under the five conditions applied (Figure 10 ). The addition of ATP or ATPγS supported the interaction but ADPβS and especially AMP suppressed it. Comparing several independent experiments, the amounts of GFP-syndapin II-l coimmunoprecipitated upon ATP or ATPγS addition were always higher or comparable to those performed under similar conditions without addition of nucleotides, and much higher than those obtained after AMP or ADβS preincubation ( Figure 10A ). These coimmunoprecipitation experiments, however, did not exclude the possibility that the observed nucleotide effects were indirect or even EHD independent.
In order to demonstrate that nucleotide binding of mRme-1/EHD1 modulates the EH domain interaction with syndapin, we performed coprecipitation analyses with immobilized syndapin II-l and HEK293 cell lysates containing wild-type GFP-mRme-1/EHD1 and different mutants. GFP-mRme-1/EHD1 G65R represents a mutant in analogy to a dominant Rme-1 mutant isolated in mutational analyses of membrane trafficking in C. elegans . The G65R exchange is located in the nucleotide binding P-loop. We hypothesized that if the N-terminal nucleotide binding domain indeed influences syndapin's association with the C-terminal EH domain, then silencing the nucleotide binding domain by mutation may interfere with syndapin binding. As a control for interfering with EH domain-dependent syndapin binding, we additionally assayed a mutant of mRme-1/EHD1 with a disrupted EH domain (GFP-mRme-1/EHD1 W485A) that was constructed based on structural data for the Eps15 EH domain 2 (de Beer et al., 2000) . Additionally, we included GFP-mRme-1/EHD1 G429R, the mammalian version of a second C. elegans Rme-1 dominant mutant.
Overexpression of mRme-1/EHD1 G429R has been observed to block recycling in several recent studies Caplan et al., 2002; Picciano et al., 2003; Park et al., 2004 ).
The molecular mechanisms by which the G429R mutation brings about this effect is however unknown.
We observed that the G65R mutant was strongly deficient for syndapin binding ( Figures 10E   and F) . The immunosignal obtained from the eluates was almost as weak as that of the EH domain mutant that served as a negative control and which lacked all specific syndapin binding activity. In contrast, the G429R mutant showed a strong syndapin binding and did not differ significantly from wild type mRme-1/EHD1 under affinity purification conditions ( Figure 10F ).
EHD mutants defective in syndapin binding do not act dominant-negatively on receptor recycling
We have demonstrated that overexpression of the syndapin-binding EH domain of mRme-1/EHD1 alone has a dominant-negative effect on transferrin recycling (Figure 9 ). Lin et al. (2001) showed that overexpression of the G65R mutant did not cause any impairment. We hypothesized that the lack of G65R-induced recycling defects is due to the observed strongly decreased syndapin binding activity of G65R mutants ( Figures 10E and F) . If this hypothesis is correct, then overexpression of the EH domain mutant (W485A) should also lack dominantnegative activity. Indeed, the W485A mutant did not cause an inhibition in recycling ( Figures   10I and K ) when compared to overexpression of the G65R mutant ( Figures 10G and K) or to untransfected cells ( Figure 10K ). In contrast, about half of all G429R overexpressing cells showed significant remaining transferrin ( Figures 10J and K) . Overexpression of a wild type,
i. e. presumably fully functional, mRme-1/EHD1, only caused extremely mild, if any, effects on transferrin recycling ( Figure 10G ). Quantitation of the effects elicited showed that only 30% of the mRme-1/EHD1 overexpressing cells were transferrin-positive ( Figure 10K ). This is consistent with a previously reported lack of inhibition of transferrin recycling . Also, recycling of a major histocompatibility complexes component and AMPA receptors was rather enhanced than inhibited (Caplan et al., 2002; Park et al., 2004) . In summary, our analysis of the different syndapin and mRme-1/EHD1 point mutants and deletion constructs revealed the critical importance of EH domain/NPF interactions for the receptor recycling process, as only proteins capable to interfere with these interactions disrupt this cellular process.
Discussion
Syndapins have been proposed to interconnect vesicle formation in receptor-mediated endocytosis and the cortical actin cytoskeleton . Our new data indicate that syndapins are parts of a more general mechanism in membrane trafficking, because they interact with EHD proteins that function in exit from the endosomal recycling compartment. Syndapin I, syndapin II-s and syndapin II-l but not syndapin III interact with EHD proteins. The interaction is based on associations of the EH domain of EHD proteins with syndapin NPF motifs, as we demonstrated by yeast two hybrid analysis, affinity purifications and in vivo reconstitution of EHD/syndapin complexes. The interaction is direct, as proven by blot overlay studies. These findings are consistent with data Xu et al. (2004) reported while this manuscript was in preparation. They showed by biochemical methods that a C-terminal part of syndapin II that encompasses the region, which contains the NPF motifs, interacts with the EH domain of EHD1 in vitro (Xu et al., 2004) . Our mutational analyses prove that the interaction indeed requires NPF motifs. Consistently, syndapin III, which does not exhibit NPF motifs, did not bind to EHD proteins. Additionally, our mutational analyses revealed that NPF 364-6 is the most important EHD-binding motif in syndapin II. This region is alternatively spliced and is absent in the short versions of syndapin II . EHD proteins therefore do not only represent the first differential in vivo binding partners for the three syndapin isoforms but can also differentiate between the long and short splice variants of syndapin II.
All syndapin NPF motifs except for one in syndapin I are preceded by one or even two (syndapin II NPF 364-6) serines. The positions and numbers of serines may correlate with the strength of interaction, as proposed for other EH domains (Salcini et al., 1997) . Our data demonstrate that syndapin EH domain interactions are quite specific for EHD proteins. Eps15
EH domains were shown to prefer basic or hydrophobic amino acids C-terminal of the NPFs (Salcini et al., 1997) . In contast, the NPFs of syndapins are directly followed by acidic or polar residues. We propose that these NPF-context differences determine the specificity for EHD proteins.
Careful comparative analyses of the EH domains of EHD proteins, intersectin and Eps15 and correlations with structural studies performed for the second Eps15 EH domain (de Beer et al., 2000) additionally reveal the molecular determinants within the EH domain that are likely to bring about the specificity of syndapins for EHD proteins ( Figure S4 ). Four positions, which are strictly conserved among EHD proteins, differ significantly from the intersectin and the Eps15 EH domains. These include the position corresponding to E163, which is a serine or threonine in all EHD proteins, and E170, which is a lysine in all EHD proteins ( Figure S4 ).
As both of these positions have been identified as residues involved in the recognition and specificity control at the +3 position, i. e. of the amino acid C-terminal of the NPF, in the structural analysis of the second Eps15 EH domain bound to the NPF-containing Hrb peptide (de Beer et al., 2000) , they may help in generating the specificity differences observed between EHD protein EH domains and those of Eps15 and intersectin. It seems likely that the highly conserved lysine in the E170 position directly contacts the negatively charged amino acids C-terminal of almost all syndapin NPFs.
However, these two differences in primary sequence cannot explain the inability of EHD2 to bind syndapins, since these two residues are conserved among all EHD proteins including the C. elegans ortholog. Interestingly, our analyses revealed two additonal positions that differ from Eps15 and intersectin EH domains but are strongly conserved among EHD proteins except in the EHD2 isoform, V154 and M203. The M203 position is taken by an asparagine or lysine in EHD1, 3 and 4 and in the C. elegans protein but is a serine in EHD2. M203 has been shown to be in direct contact with the leucine following the NPF motif in the Hrb peptide studied in complex with the second Eps15 EH domain (de Beer et al., 2000) . The asparagine and the lysine in EHD1, 3 and 4 ( Figure S4 ) may, by analogy, contact the glutamate or aspartate, which usually follows the syndapin NPFs ( Figure 2G ). The second position that is likely to explain the observed differential binding of EHD proteins corresponds to V154 and is strictly hydrophobic in Eps15 and intersectin EH domains. It is exchanged for a glutamate in EHD1, 3 and 4 but is a tryptophane in EHD2. This residue is a direct neighbor of L155 shown to be a highly conserved part of the NPF binding pocket (de Beer et al., 2000) .
Syndapins are new interaction partners of EHD proteins that were previously strongly suggested to function in the early uptake stages in the endocytic pathway . Additionally, syndapins seem to play a role in vesicle formation from Golgi membranes (Kessels et al., 2003) . The interaction with EHD proteins may also implicate them in vesicle formation from endosomal membranes. We thus propose that syndapinsare parts of a machinery widely used for vesicle formation processes from several different cellular membranes like other well known trafficking proteins such as clathrin and dynamin. (Simpson et al., 1999; . Interfering with syndapin SH3 domain functions by overexpression of the syndapin binding interface of N-WASP also blocked endocytosis and could be rescued by cooverexpression of full-length syndapin I or syndapin II .
Our current analyses, however, revealed that the syndapin region involved in EHD interaction is distinct from the SH3 domain. Manipulation of this interface allowed us to identify an involvement of syndapin function in later steps in the endocytic recycling pathway, in the is comparable to that of the known dominantly interfering mRme-1/EHD1 mutant G429R . Since the association of mRme-1/EHD1 G429R with endosomes , its oligomerization as well as its capability to bind and hydrolyse ATP is intact (Lee et al., in press) and we showed that mRme-1/EHD1 G429R still associates with syndapins, the molecular basis for this dominant interference remains unclear. The dominant-negative effect of the EH domain strongly supports our conclusion that specifically EH domain/NPF motif interactions are required for endosomal recycling and that one likely reason for the inhibition of the endocytic pathway observed upon suppression of mRme-1/EHD1 levels by gene disruption or RNAi (Naslavsky et al., 2004) is the inability of such cells to make the required EH domain-dependent interconnections with NPF motif-containing, specific EHD protein interaction partners, such as syndapins. Consistently, the recycling defect caused by overexpression of the EH domain of mRme-1/EHD1 can be rescued by coexpression of syndapin II.
Our analyses provide an explanation for the finding that overexpression of mRme-1/EHD1
G65R did not cause any inhibition in recycling ; this study). Our protein interaction studies strongly suggest that this lack of dominant-negative properties reflects the lack of EH domain function; G65R mutants were not able to associate with syndapins ( Figure   10 ). The analog mutation in the C. elegans protein disrupted dimerization of ceRme-1 (Lee et al, in press) . Provided that the mRme-1/EHD1 mutant G65R behaves similarly, overexpression of G65R mRme-1/EHD1 would neither sequester endogenous EHD proteins into dimers with the mutant protein nor interfere with endogenous EH domain/NPF interactions critical for recycling.
G65R mutants exhibit a disrupted P-loop and we found that there is some functional crosstalk of the nucleotide binding of the mRme-1/EHD1 N-terminal domain and the C-terminal EH domain interacting with syndapins. This result of our mutational analyses is also supported by the observed changes in syndapin binding to wild-type mRme-1/EHD1 in vivo when incubations with ATP, ADP, AMP and non-hydrolysable derivatives, respectively, were performed. mRme-1/EHD1 has recently been shown to be a slow ATPase (Lee et al., in press ). EH domain interactions with syndapins seem to be suppressed under conditions that reduce ATP binding or in a mutant protein where nucleotide binding is disrupted completely.
It thus seems possible that the ATPase domain of mRme-1/EHD1 is in control of the EH domain interactions with NPF motif-containing proteins that we have revealed to be crucial for an efficient recycling of receptors back to the plasma membrane.
In the G429R mutant, in contrast, the EH domain seems functional, as it bound syndapins very well, yet the protein has strong dominant-negative effects on recycling because this mutation obviously causes some non-functionality elsewhere in the molecule ; this study). The G429R mutant is strongly localized to endosomes .
Strong syndapin interactions with the G429R mutant at these membranes and the resulting partial sequestration of endogenous syndapins away from the endocytic vesicle formation machinery at the plasma membrane may be one reason for the observed slight impairment of endocytosis in G429R mutant overexpressing cells ( Figure S3 ).
One possible mechanistic role of syndapins in exit from the ERC is that they may orchestrate a dynamic interplay of EHD proteins with activators of the actin nucleation machinery and/or further components involved in membrane trafficking in analogy to their proposed function during endocytic vesicle formation Kessels and Qualmann, 2004) . This putative role would require that syndapins interact with multiple interaction partners simultaneously. As the EHD protein interaction involves the syndapin NPF motifs and all other interactions described are mediated via the SH3 domain , it seems well possible that one syndapin molecule can serve as physical link between EHD proteins and further interaction partners. Additionally, we have discovered that syndapins dimerize in a non-SH3 domain-dependent manner (Kessels and Qualmann, unpublished) . The observed clustering of EH domain-coated mitochondria upon cooverexpression of both syndapin II full-length as well as of syndapin II ΔSH3 (Figure 7) indicates that also dimerization and NPF-interactions can occur simultaneously. This is further supported by the fact that dimerization is indeed independent of the NPF region (Kessels and Qualmann, unpublished) . Syndapin dimerization strongly increase the number of possible interconnections originating from syndapin/EHD protein complexes and may therefore represent a molecular basis for the formation of multivalent, dynamic scaffolds during vesicle formation not only at the plasma membrane but also at membranes of the ERC.
In neurons, the accumulation of both EHD proteins and syndapin in perinuclear regions as well as in synaptic areas suggests that EHD protein/syndapin complexes are involved in recycling in the cell soma but also within the very small subcellular compartment of the synapse. This is supported by our subcellular fractionation data. Syndapins seem to occur both pre-and postsynaptically, as suggested by colocalizations with the synaptic vesicle protein synaptophysin (Qualmann et al., 1999) (Park et al., 2004) . The endocytosis of AMPA receptors also involves the syndapin binding partner dynamin (Carroll et al., 1999) . It therefore seems likely that molecular interconnections mediated by syndapins play important roles in both the endocytosis and the recycling of AMPA-type glutamate receptorsprocesses, which are believed to represent a mechanism for synaptic plasticity -and thereby for learning and memory formation. Western blots of rat brain homogenate and indicated subcellular fractions probed with antibodies against EHD proteins (A), syndapin I (B), the synaptic vesicle marker synaptophysin (C) and the TGN marker protein TGN38 (D). S1, 1000 x g supernatant 1; S2, 12,000 x g supernatant 2; P2, 12,000 x g pellet 2 (crude membrane fraction). Myelin, light membranes, synaptosomes and the fraction containing heavy membranes and mitochondria (mitochondria) were obtained by sucrose step gradient separation of P2. SM, 100,000 x g microsomal supernatant; PM, 100,000 x g microsomal pellet. Coimmunoprecipitation of GFP-syndapin II-l with Flag-EHD1 coexpressed in HEK293 cells.
Immunoblot analyses of immunoprecipitates (B, D) and supernatants (A, C). (E, F)
Immunoblot analyses of supernatant, immunoprecipitated material and of the rat brain extract used for coimmunoprecipitations of endogenous EHD proteins along with endogenous syndapin I, which was immunoprecipitated by anti-syndapin I antibodies. 
